Bipolar Disorder Therapeutics Pipeline Analysis, 2017 - Designation, Collaboration, and Other Developments

Bipolar disorder therapeutic pipeline analysis is expected to increase on account of increasing instances of issues related to depression and other mental disorders, across the world. Major factors driving the pipeline analysis for bipolar disorder are obesity, stress, incidence of nervous system trauma, depression, low market penetration of medicines as very small number of companies are making an analog. In addition, increasing awareness regarding health issues among people is another major factor fueling the pipeline analysis for bipolar disorder. According to National Alliance of Medical Illness, the prevalence of bipolar disorder has increased and it can occur at any age in life, mostly around 25 years of age. Every year, nearly 2.9% population in the U.S. is diagnosed with bipolar disorder, in which 83% cases are classified as severe. It is equally affecting in both males and females.

Explore Report at: www.psmarketresearch.com/market-analysis/bipolar-disorder-therapeutics-pipeline-analysis

Bipolar disorder is also known as manic depressive illness, that causes an unusual alteration in activity levels, mood, energy, and ability to carry out everyday task. Bipolar disorder is categorized into four types. Bipolar I disorder, having symptoms of manic episodes that last till seven days, and sometimes it becomes sever to the extent that the patients need hospital care. Bipolar III disorder is defined by a pattern of hypomanic episodes and depressive episodes. Cyclothymic disorder, is also known as cyclothymia, which is characterized by many periods of hypomanic symptoms, lasting for around two years. Other bipolar disorders, are of a type not related to the above three. Some bipolar disorders are also similar to other sickness such as eating disorder, substance abuse and anxiety disorder. People with bipolar disorder are at high risk of migraine, thyroid diseases, headache, diabetes, obesity, heart disease and physical illness.

Request for Table of Content at: www.psmarketresearch.com/market-analysis/bipolar-disorder-therapeutics-pipeline-analysis/toc-sample

Some of the key having a pipeline of bipolar disorder therapeutics include Aequus Pharmaceuticals Inc., ANP Technologies, Inc., AstraZeneca Plc, Convergence Pharmaceuticals Ltd., D-Pharm Ltd., Delpor, Inc., Intas Pharmaceuticals Ltd., Intra-Cellular Therapies, Inc., Johnson & Johnson Private Limited, KemPharm, Inc., Neurocrine Biosciences, Inc., Omeros Corporation, Otsuka Holdings Co., Ltd., Pfizer Inc.

Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com

347, 5th Ave. #1402
New York City, NY - 10016

This release was published on openPR.